About this trial
Drug-related iatrogenesis is a major public health issue, accounting for a significant proportion of adverse events and hospitalizations in emergency departments. Optimizing prescription management in this context is critical to improve both patient safety and physician efficiency This study aims to evaluate the impact of the POSOS AI-driven device on the medical time required for prescription management in polymedicated patients admitted to emergency departments. The main objective is to establish whether the use of POSOS can reduce transcription time compared to standard electronic management.
Eligibility criteria
Qualifiers
Age ≥18 years
Admission to emergency department at a participating center
Polymedicated patients with prescriptions including ≥8 medication lines (including those for long-term illnesses)
Signed informed consent
Disqualifiers
Patient under legal protection/judicial measures (guardianship/custody)
Lack of signed informed consent
Trial design
Treatments tested in this trial
- current hospital-standard databases
- Posos
Treatment groups
Sponsors and collaborators
Centre Hospitalier Universitaire, Amiens
Lead sponsor
Centre Hospitalier Public du Cotentin
Collaborator
University Hospital, Bordeaux
Collaborator
University Hospital, Strasbourg, France
Collaborator
Clinique de l'Estrée
Collaborator
CHU Aix-en-Provence
Collaborator